Morgan Stanley, KeyBanc Raise UNH Stock Price Targets after Strong Q2 Beat
Tip Ranks·
- UnitedHealth (UNH) reported strong Q2 earnings, exceeding expectations with an EPS of $6.38, improving its 2026 guidance to $19.50–$20.00.
- Analysts from KeyBanc and Morgan Stanley raised their price targets to $500 and $529 respectively, citing positive performance due to lower medical costs and strong results from Optum Health.
- While the stock has risen nearly 30% year-to-date, the consensus rating remains strong buy, indicating further potential for growth despite concerns over rising medical costs in commercial insurance.